Tirzepatide is a dual-receptor GIP/GLP-1 agonist that targets two metabolic pathways at once, delivering some of the most impressive weight loss results seen in clinical trials. Clients experience significant appetite reduction and body composition changes that go beyond what single-receptor medications achieve.
Like other GLP-1 therapies, Tirzepatide is a subcutaneous injection that clients self-administer at home. Your nurse will start you at the lowest effective level and adjust gradually — this is key to a comfortable experience. You'll have regular check-ins with your nurse to monitor progress and ensure you're feeling your best throughout the process.
This therapy is for general wellness support and is not intended to diagnose, treat, or cure any medical condition. Consult your healthcare provider before starting any new wellness regimen. Weight loss medications require ongoing medical supervision.